Catalyst Wire Dossier Catalyst Wire Dossier

WINREVAIR

SOTATERCEPT-CSRK · Merck Sharp & Dohme LLC
Drug timelines are a Plus or Pro feature.

9 regulatory and trial events tracked for WINREVAIR, covering 2024-03-26 to 2026-08-12. Get the full timeline:

Most recent: FDA Approved: WINREVAIR — Supplemental Application (Merck Sharp & Dohme LLC)

See pricing